SYNTHETIC BIOLOGICS, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)

Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

On January 27, 2021, the Company filed a Certificate of Amendment to the Certificate of Designation for its Series A Convertible Preferred Stock (the "Certificate of Amendment") with the Secretary of State of the State of Nevada that adjusted the conversion price from $18.90 per share to $1.50 per share and removed the redemption upon change of control.

The foregoing description of the Certificate of Amendment is qualified in its entirety by reference to the full text of the Certificate of Amendment, a copy of which is filed as Exhibit 3.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 8.01 Other Events

On January 27, 2021, the Company received notice from the holder of the Series A Preferred Stock that it was increasing the Maximum Percentage (as such term is defined in the Certificate of Designation for the Series A Convertible Preferred Stock) from 4.99% to 9.99%, such increase to be effective 61 days from the date hereof. As of the date of this Current Report on Form 8-K, the Company has 60,299,822 shares of common stock outstanding.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

     The following exhibits are filed with this Current Report on Form 8-K.




Exhibit
 Number    Description

  3.1        Certificate of Amendment to the Certificate of Designation for the
           Series A Convertible Preferred Stock

© Edgar Online, source Glimpses